• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Tune in to Podnosis: The watchdog overseeing the integrity of HHS programs

mifepristone

mifepristone
Favicon Fierce Pharma

FDA is moving forward with abortion pill safety study: WSJ

The FDA isĀ investigating the safety of mifepristone, an initiative that could allow the administration to impose restrictions on its use, WSJ reports.
Kevin Dunleavy Jun 5, 2026 11:06am
The Supreme Court building
Favicon Fierce Pharma

SCOTUS temporarily restores telehealth access to abortion pill

May 15, 2026 11:20am
US Supreme Court
Favicon Fierce Pharma

Abortion pill producers ask SCOTUS to prevent online access ban

May 4, 2026 12:05pm
FDA
Favicon Fierce Pharma

FDA takes close look at mifepristone REMS program

Sep 25, 2025 11:00am
women gender womens health International Womens Day
Favicon Fierce Biotech

Biotech leaders urge FDA to not restrict abortion pill access

Jul 2, 2025 2:14pm
Marty Makary FDA Commissioner
Favicon Fierce Pharma

Four states ask FDA to lift restrictions on mifepristone

Jun 6, 2025 8:21am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings